Neil Fleshner
Overview
Explore the profile of Neil Fleshner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
248
Citations
3832
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fleshner N, Grossman H, Berglund R, Hafron J, Inman B, Karsh L, et al.
Bladder Cancer
. 2025 Mar;
10(4):278-289.
PMID: 40035078
Background: Bladder EpiCheck (BE) is a novel methylation-based PCR urine test for the detection of non-muscle invasive bladder cancer (NMIBC) recurrences. Objective: We present the results of a North American...
2.
Bernardino R, Yin L, Lajkosz K, Cockburn J, Wettstein M, Woon D, et al.
World J Urol
. 2024 Nov;
42(1):651.
PMID: 39607443
Background: Intraductal carcinoma (IDC) and cribriform pattern (Crib) of prostate cancer are recognised as independent prognosticators of poor outcome, both in prostate biopsies and radical prostatectomy (RP) specimens. Objective: This...
3.
Sii S, Papa N, Yiu T, Tempo J, Qu L, Perera M, et al.
BJU Int
. 2024 Nov;
PMID: 39607059
Objective: To investigate the relationship between the prostate-specific antigen (PSA) free-to-total ratio (FTR) and International Society of Urological Pathology Grade Group ≥2, clinically significant prostate cancer (csPCa) in men with...
4.
Bernardino R, Carvalho A, Hall M, Alves L, Leao R, Sayyid R, et al.
Sci Rep
. 2024 Oct;
14(1):25065.
PMID: 39443544
Prognostic tests and treatment approaches for optimized clinical care of prostatic neoplasms are an unmet need. Prostate cancer (PCa) and derived extracellular vesicles (EVs) proteome changes occur during initiation and...
5.
Chavarriaga J, Penn L, Khurram N, Lajkosz K, Longo J, Chen E, et al.
Urology
. 2024 Sep;
194:172-179.
PMID: 39222671
Objective: To evaluate for the first time, comparative serum and prostate tissue concentrations of lipophilic and hydrophilic statins. Methods: After reviewing all patients who underwent radical prostatectomy between 1993 and...
6.
Hamilton R, Chavarriaga J, Khurram N, Lau C, Luo J, Liu N, et al.
JAMA Netw Open
. 2024 Aug;
7(8):e2430223.
PMID: 39190306
Importance: 5-alpha-reductase-inhibitors (5-ARIs) are approved for treating benign prostatic hyperplasia (BPH) and have been found to reduce prostate cancer (PCa) risk by 25%. However, trials also have shown 5-ARIs to...
7.
Peretsman S, Emberton M, Fleshner N, Shoji S, Bahler C, Miller L
World J Urol
. 2024 Mar;
42(1):175.
PMID: 38507093
Purpose: To characterize patient outcomes following visually directed high-intensity focused ultrasound (HIFU) for focal treatment of localized prostate cancer. Methods: We performed a systematic review of cancer-control outcomes and complication...
8.
Shore N, Gratzke C, Feyerabend S, Werbrouck P, Carles J, Vjaters E, et al.
Oncologist
. 2024 Feb;
29(7):581-588.
PMID: 38394384
Background: Patients with nonmetastatic castration-resistant prostate cancer (nmCRPC) are usually asymptomatic and seek treatments that improve survival but have a low risk of adverse events. Darolutamide, a structurally distinct androgen...
9.
Kofanova O, Paul S, Pexaras A, Bellora C, Petersons A, Schmitt M, et al.
Biopreserv Biobank
. 2023 Oct;
22(3):257-267.
PMID: 37878356
Development of novel biomarkers for diagnosis of disease and assessment of treatment efficacy utilizes a wide range of biospecimens for discovery research. The fitness of biospecimens for the purpose of...
10.
Navarro-Domenech I, Arulanantham S, Liu Z, Tjong M, Kong V, Malkov V, et al.
Radiat Oncol
. 2023 Sep;
18(1):154.
PMID: 37730609
Purpose/objective: Definitive radiotherapy (RT) is an alternative to radical cystectomy for select patients with muscle invasive bladder cancer (MIBC); however, there is limited data on dose-painted RT approaches. We report...